Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models

As a novel orally active multitarget small molecule inhibitor, CS2164 has shown broad antitumor activities against several human tumor xenograft models in immune-compromised mice. However, the ability of CS2164 to modulate antitumor immunity in an immune-competent mouse tumor model remains undefined...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Anticancer Drugs
Päätekijät: Zhou, You, Fu, Chao, Kong, Yidi, Pan, Desi, Wang, Yanan, Huang, Shengjian, Li, Zhibin, Ning, Zhiqiang, Lu, Xianping, Shan, Song, Xin, Lijun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2019
Aiheet:
Preclinical Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749973/
https://ncbi.nlm.nih.gov/pubmed/30998512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000791
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia